Premium
Adverse effect of smoking on prognosis in human papillomavirus–associated oropharyngeal carcinoma
Author(s) -
Liskamp Carmen P.,
Janssens Geert O.,
Bussink Johan,
Melchers Willem J.,
Kaanders Johannes H.,
Verhoef Cornelia G.
Publication year - 2016
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.24516
Subject(s) - medicine , multivariate analysis , oncology , human papillomavirus , retrospective cohort study , medical record , cohort , comorbidity , radiation therapy , adverse effect
Background The purpose of this retrospective study was to identify prognostic factors in a cohort of patients with oropharyngeal carcinoma treated with intensity‐modulated radiotherapy (IMRT). Methods Medical records of 142 patients treated with (chemo)radiotherapy between September 2005 and September 2011 were reviewed and the human papillomavirus (HPV) status was determined by polymerase chain reaction (PCR) analysis. Potential prognostic factors for 3‐year locoregional control and overall survival (OS) were evaluated. Results HPV‐positive patients ( n = 82) had locoregional control and OS of 78% and 79%, respectively. Significant prognostic factors on multivariate analysis were smoking ( p = .03) for locoregional control and OS, and comorbidity ( p = .04) for OS. Further stratification was done according to smoking behavior in HPV‐positive patients. Locoregional control in current smokers was 67% compared to 86% in never smokers and former smokers, respectively ( p = .02). Conclusion Smoking was the only modifiable prognostic factor in HPV‐positive patients. Therefore, active stop‐smoking programs must be integrated in the routine management of patients to maximize treatment results. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1780–1787, 2016